Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

HeMemics Biotechnologies

HeMemics Biotechnologies
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
$2.5M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of a cell preservation platform designed to dehydrate biologics in dried or partially dried format for wider distribution and ease of use. The company's platform allows preserving of mammalian cells and biologics in desiccated and non-desiccated formats in cold or ambient temperature instead of frozen format, enabling medical practitioners to stabilize biologics in a dried or partially dried format for less damage to proteins or cells, ease of storage, transport and extended shelf-life.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 708 Quince Orchard Road
  • Suite 250A
  • Gaithersburg, MD 20850
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore HeMemics Biotechnologies’s full profile, request a free trial.

HeMemics Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 11-Dec-2019 $2.5M 00.000 Completed Generating Revenue
6. Seed Round 15-Oct-2018 00.00 00.000 00.00 Completed Startup
5. Angel (individual) 25-May-2018 00000 00000 Completed Startup
4. Seed Round 18-Dec-2017 00000 Completed Startup
3. Accelerator/Incubator 01-Dec-2017 00000 Completed Startup
2. Grant 01-Jan-2012 $185K $107K Completed Startup
1. Accelerator/Incubator 13-Aug-2007 $107K $107K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

HeMemics Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Seed 2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
To view this company’s complete Cap Table, request access »

HeMemics Biotechnologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
American Vietnamese Investment Partners Venture Capital Minority 000 0000 000000 0
Inova Strategic Investments Corporate Venture Capital Minority 000 0000 000000 0
Inova Personalized Health Accelerator Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Maryland Industrial Partnerships Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

HeMemics Biotechnologies Executive Team (7)

Name Title Board
Seat
Contact
Info
John Warden Jr. Co-Founder & Chief Executive Officer
Bruce Campbell President & Board Member
David Ho Ph.D Co-Founder, Chief Scientific Officer & Board Member
James Hogarty Executive Officer & Board Member
Roger Brook Executive Officer & Board Member
You’re viewing 5 of 7 executives. Get the full list »

HeMemics Biotechnologies Board Members (7)

Name Representing Role Since Contact
Info
Bruce Campbell HeMemics Biotechnologies President & Board Member 000 0000
David Ho Ph.D HeMemics Biotechnologies Co-Founder, Chief Scientific Officer & Board Member 000 0000
James Hogarty HeMemics Biotechnologies Executive Officer & Board Member 000 0000
Larry Simpson HeMemics Biotechnologies Board Member 000 0000
Michael Thomas Self Executive Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »